The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
The mTOR Kinase Determines Effector versus Memory CD8+ T Cell Fate by Regulating the Expression of Transcription Factors T-bet and Eomesodermin
Open accessAbstract
The mechanisms underpinning integration of instructions that program naive CD8+ T cells for effector and/or memory differentiation are not well understood. Herein, we demonstrate that interleukin-12 (IL-12) enhanced and sustained antigen and costimulatory molecule (B7.1)-induced mTOR kinase activity in naive CD8+ (OT-I) T cells via phosphoinositide 3-kinase and STAT4 transcription factor pathways. Blocking mTOR activity by rapamycin reversed IL-12-induced effector functions because of loss of persistent expression of the transcription factor T-bet. Rapamycin treatment of IL-12-conditioned OT-I cells promoted persistent Eomesodermin expression and produced memory cell precursors that demonstrated enhanced sustenance and antigen-recall responses upon adoptive transfer. The memory cell precursors showed greater tumor efficacy than IL-12-conditioned effector OT-I cells. These results identify mTOR as the central regulator of transcriptional programs that determine effector and/or memory cell fates in CD8+ T cells. Targeting mTOR activity offers new opportunities to regulate CD8+ T cell-mediated immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consistent with this, the drug rapamycin, which also inhibits mTORC1, enhances the generation of CD8 TM cells (17, 19, 20).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787 · cited 3×
“It is possible that mTOR, which has been shown to tether several transcriptional factors (both activators and repressors) (Wullschleger et al., 2006) may regulate T-bet expression based on its activity.”
BackgroundInfluentialUpstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181 · cited 2×
“Although the kinase mTOR has been implicated as an integrator of various extracellular signals and a sensor for internal energy levels for determination of cell fate (Hay and Sonenberg, 2004), the role for mTOR in integrating instructions that program naive CD8 T cells for type I effector differentiation is unclear.”
BackgroundA Novel Transcription Factor, T-bet, Directs Th1 Lineage Commitment
Szabo, S. J., Kim, S. T., Costa, G. L., Zhang, X., Fathman, C. G., & Glimcher, L. H. (2000) · Cell · doi:10.1016/s0092-8674(00)80702-3 · Cited by 3,589 · cited 1×
“The transcription factor T-bet (Tbx21) is the master regulator of type I effector differentiation whose expression is considerably enhanced and sustained in the presence of IL-12 (Joshi et al., 2007; Szabo et al., 2000).”
BackgroundCancer regression in patients after transfer of genetically engineered lymphocytes
Morgan, R. A., Dudley, M. E., Wunderlich, J. R., Hughes, M. S., Yang, J. C., Sherry, R. M., Royal, R. E., Topalian, S. L., Kammula, U. S., Restifo, N. P., et al. (2006) · Science · doi:10.1126/science.1129003 · Cited by 2,603 · cited 2×
“Rapamycin-Treated IL-12-Conditioned OT-I Cells Demonstrate Augmented Tumor Efficacy The use of ex vivo generated tumor-antigen-specific effector CD8 T cells in adoptive cell transfer (ACT) has produced tumor regressions in the clinical setting (Morgan et al., 2006).”
BackgroundTOR, a Central Controller of Cell Growth
Schmelzle, T., & Hall, M. N. (2000) · Cell · doi:10.1016/s0092-8674(00)00117-3 · Cited by 1,914 · cited 2×
“In agreement, with the reported role for mTOR in regulating cell size (Schmelzle and Hall, 2000) and the expression of L-type amino acid transporter (CD98) (Cornish et al.”
BackgroundLineage relationship and protective immunity of memory CD8 T cell subsets
Wherry, E. J., Teichgräber, V., Becker, T. C., Masopust, D., Kaech, S. M., Antia, R., von Andrian, U. H., & Ahmed, R. (2003) · Nature Immunology · doi:10.1038/ni889 · Cited by 1,864 · cited 2×
“We performed phenotypic analysis of OT-I cells using markers associated with memory precursor CD8+ T cells, i.e., CD62L (lymph node homing) (Wherry et al., 2003), CD69 (lymph node retention) (Shiow et al., 2006), CD127 (IL-7Ra; essential for memory T cell maintenance) (Schluns et al., 2000), CD122…”
MethodJoshi, N. S., Cui, W., Chandele, A., Lee, H. K., Urso, D. R., Hagman, J., Gapin, L., & Kaech, S. M. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.010 · Cited by 1,861 · cited 9×
“Several transcription factors have been shown to coordinate and regulate the balance between long-lived memory and terminally differentiated effector CD8+ T cells (Intlekofer et al., 2005; Joshi et al., 2007; Welsh, 2009).”
BackgroundInfluentialInterleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo
Schluns, K. S., Kieper, W. C., Jameson, S. C., & Lefrançois, L. (2000) · Nature Immunology · doi:10.1038/80868 · Cited by 1,619 · cited 2×
“…node homing) (Wherry et al., 2003), CD69 (lymph node retention) (Shiow et al., 2006), CD127 (IL-7Ra; essential for memory T cell maintenance) (Schluns et al., 2000), CD122 (IL-15Rb and essential for memory CD8+ T cell homeostatic renewal) (Schluns et al., 2002), KLRG1 (inversely corelated…”
BackgroundmTOR regulates memory CD8 T-cell differentiation
Araki, K., Turner, A. P., Shaffer, V. O., Gangappa, S., Keller, S. A., Bachmann, M. F., Larsen, C. P., & Ahmed, R. (2009) · Nature · doi:10.1038/nature08155 · Cited by 1,575
Enhancing CD8 T-cell memory by modulating fatty acid metabolism
Pearce, E. L., Walsh, M. C., Cejas, P. J., Harms, G. M., Shen, H., Wang, L.-S., Jones, R. G., & Choi, Y. (2009) · Nature · doi:10.1038/nature08097 · Cited by 1,559 · cited 6×
“…reports have demonstrated the role of mTOR in regulating CD8+ T cell trafficking (Sinclair et al., 2008) and memory differentiation (Araki et al., 2009; Pearce et al., 2009), but the molecular mechanisms by which mTOR regulates CD8+ T cell differentiation or trafficking remain uncharacterized.”
BackgroundInfluential
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 655
Immunoregulation: the interplay between metabolism and redox homeostasis
Perpiñán, E., Fueyo, A. S., & Safinia, N. (2023) · Frontiers in Transplantation · doi:10.3389/frtra.2023.1283275 · Cited by 6
Phenotypic and Immunometabolic Aspects on Stem Cell Memory and Resident Memory CD8+ T Cells
Manna, M. P. L., Azgomi, M. S., Tamburini, B., Badami, G. D., Mohammadnezhad, L., Dieli, F., & Caccamo, N. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.884148 · Cited by 6
Obesity: A comorbidity-acquired immunodeficiency syndrome (CAIDS)
Siopis, G. (2022) · International Reviews of Immunology · doi:10.1080/08830185.2022.2083614 · Cited by 6
CRISPR screening identifies T cell-intrinsic regulators of CD3-bispecific antibody responses
Molony, R. D., Funk, T., Trabucco, G. M., Corcoran, E., Ruddy, D. A., Varadarajan, M., Elliot, G., Piquet, M., Lam, J. W., Meyer, M. J., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.909979 · Cited by 6
“These findings al ign wel l with seminal reports demonstrating that mTOR inhibition can favor memory-like CD8+ T cell differentiation at the expense of effector T cell responsivity (39).”
BackgroundStieg, D. C., Parris, J. L. D., Yang, T. H. L., Mirji, G., Reiser, S. K., Murali, N., Werts, M., Barnoud, T., Lu, D. Y., Shinde, R. S., et al. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0149 · Cited by 6
“Moreover, the increased expression of Tbet, a transcription factor controlling T-cell effector function, is also driven by mTOR activity (54).”
BackgroundMilone, M. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800885-0.00001-1 · Cited by 6
Utilizing a Retroviral RNAi System to Investigate In Vivo mTOR Functions in T Cells
Araki, K., & Konieczny, B. T. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-430-8_19 · Cited by 6
mTOR is critical for intestinal T-cell homeostasis and resistance to Citrobacter rodentium
Lin, X., Yang, J., Wang, J., Huang, H., Wang, H., Chen, P., Wang, S., Pan, Y., Qiu, Y., Taylor, G. A., et al. (2016) · Scientific Reports · doi:10.1038/srep34939 · Cited by 6
Táborská, P., Stakheev, D., Svobodová, H., Strizova, Z. O., Bartůňková, J., & Smrž, D. (2020) · Cancers · doi:10.3390/cancers12123766 · Cited by 6
Ou-Yang, C.-W., Zhu, M., Sullivan, S. A., Fuller, D. M., & Zhang, W. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203163 · Cited by 6
CD8 T Cell Memory to Pathogens
Kalia, V., Ahmed, R., & Sarkar, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.14012-3 · Cited by 6
Studies of Foxo1 over the Past 25 Years: Mechanisms of Insulin Resistance and Glucose Dysregulation
Yang, W., Guo, J. Z., Song, J., & Guo, S. (2026) · Cells · doi:10.3390/cells15020109 · Cited by 5
“Upon stimulation by inflammatory cytokine, such as IL-12, T-bet is upregulated to promote differentiation of CD8 + T cells into short-lived effector cells, whereas Eomesodermin (Eomes), which is required for the differentiation of long-lived memory CD8 + T cells, is downregulated [114,115].”
Impact of multiple hits with cognate antigen on memory CD8+ T-cell fate
Takamura, S. (2020) · International Immunology · doi:10.1093/intimm/dxaa039 · Cited by 5
Glutamine Uptake and Immunomodulation: An Overview
Frauwirth, K. A. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1932-1_4 · Cited by 5
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) regulates CTL activation and memory programming
Sun, Z., & Xiao, Z. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.05.011 · Cited by 5
c-Myc and AP4: a relay team for metabolic reprogramming of CD8+ T cells
Karmaus, P. W. F., & Chi, H. (2014) · Nature Immunology · doi:10.1038/ni.2962 · Cited by 6
mTOR modulates CD8+ T cell differentiation in mice with invasive pulmonary aspergillosis
Wang, H., Xiao, Y. P., Su, L., Cui, N., & Liu, D. (2018) · Open Life Sciences · doi:10.1515/biol-2018-0018 · Cited by 5
“Furthermore, a recent study indicated that IL-12 could enhance T-bet and inhibit Eomes expression to favor the generation of effector CD8+ T cells versus memory CD8+ T cells [11].”
BackgroundInfluentialOladipo, O. O., Adedeji, B. O., Adedokun, S. P., Gbadamosi, J. A., & Salaudeen, M. (2022) · Immunologic Research · doi:10.1007/s12026-022-09353-1 · Cited by 5
Dutt, S., Gonzales, J., Boyett, M., Costanzo, A. E., Han, P. P., Steinberg, S. M., McKay, D. B., & Jameson, J. (2017) · Transplantation Direct · doi:10.1097/txd.0000000000000663 · Cited by 5
Programmed T cell differentiation: Implications for transplantation
Crepeau, R. L., & Ford, M. L. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104099 · Cited by 5
Chentoufi, A. A., Khan, A. A., Srivastava, R., Karan, S., Lekbach, Y., Vahed, H., & BenMohamed, L. (2025) · Viruses · doi:10.3390/v17050606 · Cited by 5
“In CD8 + T cells, T-bet is upregulated upon activation and is associated with the induction of effector functions [45].”
Kinase Suppressor of Ras 1 Is Not Required for the Generation of Regulatory and Memory T Cells
Borgne, M. L., Filbert, E. L., & Shaw, A. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057137 · Cited by 6
“However, this cannot explain the normal memory CD8+ T cell development in KSR1-/- mice, as sustained mTORC1 activation is thought to be required for the acquisition of effector function by CD8+ T cells at the expense of memory CD8+ T cell generation [9].”
BackgroundInfluentialP21‐activated kinase 2 is essential in maintenance of peripheral Foxp3+ regulatory T cells
Choi, J., Pease, D. R., Chen, S., Zhang, B., & Phee, H. (2018) · Immunology · doi:10.1111/imm.12886 · Cited by 4
Effect of rapamycin on repeated immobilization stress-induced immune alterations in the rat spleen
Rokytová, I., Mravec, B., Lauková, M., & Vargovič, P. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577309 · Cited by 4
Partial STAT5 signaling is sufficient for CD4+ T cell priming but not memory formation
Fleury, M., Vazquez‐Mateo, C., Escalante, J. H., & Dooms, H. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155770 · Cited by 4
mTOR Signaling Regulates the Development and Therapeutic Efficacy of PMN-MDSCs in Acute GVHD
Li, X., Li, Y., Yu, Q., Xu, L., Fu, S., Wei, C., Wang, L., Luo, Y., Shi, J., Qian, P., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.741911 · Cited by 5
“The activity of mTOR affects the differentiation and functions of various innate and adaptive immune cells, including effector T cells, Tregs, and antigen-presenting cells (Delgoffe et al., 2009; Thomson et al., 2009; Rao et al., 2010).”
BackgroundChen, W., Wan, X., Ukah, T., Miller, M. M., Barik, S., Cattin-Roy, A. N., & Zaghouani, H. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1601032 · Cited by 4
Effector functions of memory CTLs can be affected by signals received during reactivation
Lv, Y., Mattson, E., Bhadurihauck, A., Garcia, K. Y., Li, L., & Xiao, Z. (2017) · Immunologic Research · doi:10.1007/s12026-017-8920-4 · Cited by 4
“Activation of naive CTLs correlates to the expression of T-bet, a transcription factor involved in the regulation of IFNγ [5, 32].”
BackgroundTumor Microenvironment Cellular Crosstalk Predicts Response to Adoptive TIL Therapy in MelanomaPreprint
Barras, D., Ghisoni, E., Chiffelle, J., Orcurto, A., Dagher, J., Fahr, N., Benedetti, F., Crespo, I., Zimmermann, S., Durán, R., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.23.519261 · Cited by 4
“S3I), implying that a subset of Tex cells may not have transitioned to terminal exhaustion (30, 31), as suggestd also by proliferation.”
BackgroundZheng, Y., Yang, C., Xiao, G., Lei, M., Qin, P., Chen, H., & Lin, H. (2025) · International Journal of Medical Sciences · doi:10.7150/ijms.106133 · Cited by 3
“Prior research underscores EOMES's role in CD8+ T cell differentiation and anti-tumor immunity [28-31].”
Addressing tumour tolerance to improve cancer immunotherapy
Meyer, R. G., & Herr, W. (2010) · European Journal of Immunology · doi:10.1002/eji.201090067 · Cited by 3
Roles of Mechanistic Target of Rapamycin in the Adaptive and Innate Immune Systems
Kato, H., & Perl, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802733-2.00024-4 · Cited by 3
Harnessing Stem Cell-Like Memory T Cells for Adoptive Cell Transfer Therapy of Cancer
Lugli, E., & Gattinoni, L. (2015) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-21167-1_8 · Cited by 5
Increased Immunogenicity Through Autophagy
Jagannath, C., Khan, A., & Wang, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809819-6.00004-6 · Cited by 3
Fowler, D. H. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812630-1.00012-8 · Cited by 3
Autophagy enhances the Efficacy of BCG Vaccine
Khan, A., Singh, C. R., Soudani, E., Bakhru, P., Saikolappan, S., Cirillo, J. D., Eissa, N. T., Dhandayuthapani, S., & Jagannath, C. (2014) · Wiley eBooks · doi:10.1002/9781118677551.ch15 · Cited by 3
Epigenetic Regulation of CD8 + Effector T Cell Differentiation by PDCD5
Jin, L., Zhang, X., Wang, J., Wang, Y., Wang, K., Wang, Z., Wang, P., Sun, X., Hao, J., Jin, R., et al. (2025) · European Journal of Immunology · doi:10.1002/eji.202451388 · Cited by 2
PI3K Isoforms in CD8+ T Cell Development and Function
Gaur, P., Mkrtichyan, M., Verma, V., Jafarzadeh, N., Hattar, M., Gupta, S., & Khleif, S. N. (2022) · Current topics in microbiology and immunology · doi:10.1007/978-3-031-06566-8_9 · Cited by 2
Leptin, Immune Function, and Inflammation
Matarese, G., Procaccini, C., Pucino, V., & Mantzoros, C. S. (2014) · Springer eBooks · doi:10.1007/978-3-319-09915-6_11 · Cited by 2
Barkhordarian, A., Chiappelli, F., & Demerjian, G. G. (2018) · Springer eBooks · doi:10.1007/978-3-319-76367-5_3 · Cited by 2
Buela, K.-A. G. (2015) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 2
Mammalian Target of Rapamycin (mTOR)
Jacinto, E., & Werlen, G. (2016) · Compendium of Inflammatory Diseases · doi:10.1007/978-3-7643-8550-7_135 · Cited by 2
Pharmacological potential of seaweed-associated heterotrophic Firmicutes
Asharaf, S., & Chakraborty, K. (2022) · Letters in Applied Microbiology · doi:10.1111/lam.13780 · Cited by 2
“Those bioactive compounds safeguard the host from the infective group of pathogens (Rao et al. 2010).”
BackgroundZech, M., Veliça, P., & Stauss, H. J. (2015) · Current Gene Therapy · doi:10.2174/1566523215666150126123037 · Cited by 1
“In vitro activation of T cells prior to transduction in the presence of rapamycin which can pharmacologically inhibit mTOR results in greater tumour protection upon adoptive transfer of the transduced cells in vivo through preserving memory characteristics and functions [52].”
BackgroundPD ‐1 expressing islet‐specific CD4 + T cells promote bystander tolerance and prevent autoimmunity
Naranjo, J. D. L., Zhang, V., Ravichandran, R., Bergot, A., Thomas, R., & Hamilton‐Williams, E. E. (2025) · Immunology and Cell Biology · doi:10.1111/imcb.70044 · Cited by 1
CD318 expression defines a novel subset of human CD8 + regulatory T cells
Do, J., Chen, W., Hung, Y., Arribas-Layton, D., Lu, C., Gu, A., Montero, E., Carmo, A. M., & Reijonen, H. (2026) · Science Advances · doi:10.1126/sciadv.adz4203 · Cited by 1
Rochman, Y., Melamed, J. R., Klingler, A. M., Kotliar, M., Rochman, M., Caldwell, J. M., Felton, J. M., Osswald, G. A., Muscat-Rivera, J., Kegel, M., et al. (2026) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2026.05.023 · Cited by 1
mTOR mixes up a recipe for success
Minton, K. (2010) · Nature reviews. Immunology · doi:10.1038/nri2716 · Cited by 1
mTOR and its Physiological Impacts-Part II: Immunological Impact
Tse, T. M., & Kwan, P. (2013) · Cited by 1
SLE: a Metabolic Disease of T Cells?
Talabér, G., & Perl, A. (2011) · Rheumatology Current Research · doi:10.4172/2161-1149.1000e103 · Cited by 1
“The role of mTOR has also been implicated in non-autoimmune diseases, such as diabetes and cancer [9], but besides lupus as above, data are accumulating, that mTOR signaling play a very important role in both physiological and pathological T cell homeostasis and death. mTOR regulates the differentiation of CD8+ memory…”
BackgroundMetabolic aspects of adoptive immunotherapy of tumors
Kazanskiy, D. B., Silaeva, Y. Y., Kalinina, A. A., Zamkova, M. A., Khromykh, L. M., Александровна, П. Н., & Dzholokhava, L. K. (2017) · Advances in molecular oncology · doi:10.17650/2313-805x-2017-4-3-21-26 · Cited by 1
Fowler, D. H. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416004-0.00011-2 · Cited by 2
Cytotoxic T Lymphocytes and Their Granzymes: An Overview
Noonan, J., & Murphy, B. M. (2015) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-319-17807-3_5 · Cited by 1
Nyanhete, T. E., & Tomaras, G. D. (2018) · AIDS · doi:10.1097/qad.0000000000002008 · Cited by 1
Graft Versus Host Disease (GHVD) in Critically Ill Oncologic Patients
Bayraktar, U. D. (2018) · Springer eBooks · doi:10.1007/978-3-319-74698-2_31-1 · Cited by 1
Tumor-Induced Metabolism and T Cells Located in Tumor Environment
Iranparast, S., Tayebi, S., Ahmadpour, F., & Yousefi, B. (2020) · Current Cancer Drug Targets · doi:10.2174/1568009620666200720010647 · Cited by 1
The Role of Immune Checkpoints in Cancer Progression
Prasetya, R. A., & Wulansari, D. D. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.105628 · Cited by 1
Immunomodulatory properties of the HIV-1 Tat protein
Nicoli, F. (2013) · doi:10.5282/edoc.17493 · Cited by 1
INDUCTION OF STRONGER AND LONG LASTING VACCINE IMMUNITY TO TUBERCULOSIS
Bakhru, P. (2012) · Digital Commons-TMC (Texas Medical Center) · Cited by 1
Mammalian Target of Rapamycin (mTOR)
Jacinto, E., & Werlen, G. (2015) · Encyclopedia of Inflammatory Diseases · doi:10.1007/978-3-0348-0620-6_135-1 · Cited by 1
Shourian, M., Bourdin, B., El-Hachem, N., Ruisseaux, C., Vallée, A., Roméro, H., Kwarteng, E. O., Haddad, É., Lavallée, V., Beltra, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.14.651875 · Cited by 1
Salgado, P. D. C. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.9.2012.tde-09122013-102055
The Role of TIPE2 in the Regulation of Inflammation and Tumorigenesis
Johnson, D. (2013) · Scholarly Commons (University of Pennsylvania)
Current Pathways for Immune Manipulation
Lees, J. R., Azimzadeh, A. M., Ding, Y., Xu, J., & Bromberg, J. S. (2014) · Wiley eBooks · doi:10.1002/9781118873434.ch17
CD8+ T-cell responses in a Th2-polarized inflammatory setting
Kurzweil, V. (2013) · ScholarlyCommons (University of Pennsylvania)
Gubser, P. M. (2013) · edoc (University of Basel) · doi:10.5451/unibas-006161384
“Rapamycin decreased mTOR activity and led to a decrease in T-bet and a subsequent upregulation of eomesodermin (Rao et al., 2010).”
BackgroundIntrinsic Mechanisms that Regulate T Cell Homeostasis and Function
O’Brien, T. (2011) · DukeSpace (Duke University)
Neurofibromin and IL-4 as Regulators of T Cell Development, Function, and Homeostasis
Oliver, J. A. (2012) · Deep Blue (University of Michigan)
The role of interleukin-12 for mTOR regulation of memory CTLs
Garcia, K. (2014) · University Libraries (University of Maryland) · doi:10.13016/m2330m
Watkin, L. B. (2012) · eScholarship@UMassChan · doi:10.13028/kbrp-ny05
“The inflammatory cytokine IL-12 effectively promotes effector cell differentiation through mTORdependent T-bet induction (Takemoto et al., 2006; Badovinac et al., 2007a; Rao et al., 2010).”
BackgroundJB Review Pleiotropic roles of mTOR complexes in haemato-lymphopoiesis and leukemogenesis
Hoshii, T., Matsuda, S., & Hirao, A. (2014)
Dynamic Tuning of Lymphocytes: Physiological Basis, Mechanisms, and
Grossman, Z., & Paul, W. E. (2015)
Understanding CD8 T cell function under the tumour environment condition hypoxia
Townsend, K. N. (2012) · UVic’s Research and Learning Repository (University of Victoria)
Clinthorne, J. F. (2013) · Michigan State University Libraries · doi:10.25335/m5zq68
Karlsson, E. A. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/z7a5-ph53
Mineharu, Y., Kamran, N., Lowenstein, P. R., & Castro, M. G. (2014)
Cellular Metabolism Controls Lymphocyte Activation and Differentiation
Powell, J. D., & Sun, I. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.11013-6
Bergerhoff, K. F. (2016) · UCL Discovery (University College London)
Effects of Ageing on Adaptive Immune Responses
Henson, S. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-43365-3_2
“mTORC1 activity is a requirement for the generation of effector molecules [52], and despite highly differentiated CD8+ T cells apparent lack of mTOR activity they are highly potent effectors [26, 27].”
BackgroundRapamycin-induced Allograft Tolerance: Elucidating Mechanisms and Biomarker Discovery
Urbanellis, P. (2011) · TSpace (University of Toronto)
Cancer After Kidney Transplantation
Snanoudj, R., Dantal, J., Lebbé, C., & Legendre, C. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801734-0.00037-0
Donnelly, R. P. (2016) · Arrow@dit (Dublin Institute of Technology)
Immunometabolizm czyli jak procesy biochemiczne kontrolują funkcje obronne leukocytów
Cichoń, I., & Kołaczkowska, E. (2017)
The Role of TMEM127 in mTOR Pathway and Cancer Suppression
Wang, Q., & Wang, K. (2019) · International Journal of Sciences · doi:10.18483/ijsci.1985
“mTOR is considered as an important eukaryotic cell signal, coordinates cell growth and metabolism, affects transcription and protein synthesis, regulates cell apoptosis and autophagy [6, 7], and its stability affects the expression of cytokines in T cells and participates in immunosuppression [7-10].”
BackgroundZhou, A. (2018) · TSpace (University of Toronto)
Chiappetta, G. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7670
Molecular Regulation of SATB1 in Regulatory T-cells
Thabet, Y. (2013) · bonndoc (University of Bonn)
Zidan, A. A., & Tuorkey, M. J. (2020) · International Journal of Cancer and Biomedical Research · doi:10.21608/jcbr.2020.23254.1011
Characterizing the Development of T cell Exhaustion Independent of PD-1
Freeman, Z. T. (2016)
Destiny of CD8+ T cells exhaustion in cancer, and rescue of it: a narrative review
Wu, G. (2021) · Annals of Blood · doi:10.21037/aob-21-2
“Accordingly, Eomes and T-bet contribute to importance transcription factors which can regulate the antiviral and antitumor functions of effector as well as memory CD8 T cells (62-66).”
BackgroundDifferential Maintenance, Function, and Transcriptional Profile of CD8⁺ T cells with Age
Renkema, K. R. (2013) · UA Campus Repository (The University of Arizona)
Khan, A. A., Srivastava, R., Vahed, H., & BenMohamed, L. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.05.475169
Faculty Opinions recommendation of Understanding subset diversity in T cell memory.
Pipkin, M. E. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732725574.793562831
(2010) · Nature Immunology · doi:10.1038/ni0410-287
T-Cell Immunotherapy: From Synthetic Biology to Clinical Practice
Schneider, D., & Orentas, R. J. (2020) · Springer eBooks · doi:10.1007/978-3-030-50287-4_12
Metadata
- Authors
- Rao, R. R., Li, Q., Odunsi, K., & Shrikant, P. A.
- Affiliations
- Roswell Park Comprehensive Cancer Center (US)
- Corresponding author
- Shrikant, Protul A.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2010-01
- Volume
- 32
- Issue
- 1
- Pages
- 67-78
- ISSN
- 1074-7613 (ISSN-L)
- PMC
- PMC5836496
- OpenAlex
- W2059689009
- Cited by
- 656
- References
- 41
- Citations by year
- 2026: 15 · 2025: 23 · 2024: 15 · 2023: 24 · 2022: 41 · 2021: 40 · 2020: 36 · 2019: 38 · 2018: 44 · 2017: 39 · 2016: 43 · 2015: 63 · 2014: 49 · 2013: 66 · 2012: 54
- FWCI
- 25.52
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA158318, R01CA104645, P30CA016056)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- mTOR kinase, CD8+ T cells, T-bet, Eomesodermin, IL-12, phosphatidylinositol 3-kinase, STAT4, rapamycin, naive T cell differentiation, cancer immunotherapy
- MeSH terms
- T-bet Transcription Factor, Animals, Cell Differentiation, Immunologic Memory, Lymphocyte Activation, Mice, Transgenic, Transduction, Genetic, Signal Transduction, T-Lymphocyte Subsets, Protein Serine-Threonine Kinases, CD8-Positive T-Lymphocytes, T-Box Domain Proteins, Intracellular Signaling Peptides and Proteins, Mice, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
